UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Updated Reference Intervals for Alanine Aminotransferase in a Metabolically and Histologically Normal Population

Clinical gastroenterology and hepatology, 2024-11, Vol.22 (11), p.2240-2249.e6

2024

Volltextzugriff (PDF)

Stereotactic body radiotherapy alone versus stereotactic body radiotherapy after incomplete transarterial therapy for hepatocellular carcinoma

Journal of medical imaging and radiation oncology, 2024-10

2024

Volltextzugriff (PDF)

Higher risk of proteinuria with atezolizumab plus bevacizumab than lenvatinib in first-line systemic treatment for hepatocellular carcinoma

Liver cancer (Basel ), 2024-10, p.1-26

2024

Volltextzugriff (PDF)

Revisiting the steatosis‐associated fibrosis estimator score in young Asian subjects with steatotic liver disease and consideration for population variability

Journal of gastroenterology and hepatology, 2024-10, Vol.39 (10), p.2112-2119

2024

Volltextzugriff (PDF)

Clinical and Radiologic Predictors of Response to Atezolizumab-Bevacizumab in Advanced Hepatocellular Carcinoma

Cancer Research and Treatment, 2024, 56(4), , pp.1219-1230

2024

Volltextzugriff (PDF)

Viral Load-Based Prediction of Hepatocellular Carcinoma Risk in Noncirrhotic Patients With Chronic Hepatitis B : A Multinational Study for the Development and External Validation of a New Prognostic Model

Annals of internal medicine, 2024-10, Vol.177 (10), p.1308-1318

2024

Volltextzugriff (PDF)

Outcomes of liver resection and transarterial chemoembolization in patients with multinodular BCLC-A hepatocellular carcinoma

Journal of Liver Cancer, 2024, 24(2), , pp.178-191

2024

Volltextzugriff (PDF)

Dynamic liver volume change in predicting hepatic decompensation and long‐term effects of stereotactic body radiation therapy

Journal of gastroenterology and hepatology, 2024-08, Vol.39 (8), p.1648-1655

2024

Volltextzugriff (PDF)

A Study on the Improvement of the Superconducting Magnet System for the 28 GHz SC-ECRIS at KBSI

IEEE transactions on applied superconductivity, 2024-08, Vol.34 (5), p.1-5

2024

Volltextzugriff (PDF)

Tenofovir Is Associated With a Better Prognosis Than Entecavir for Hepatitis B Virus–Related Hepatocellular Carcinoma

Clinical gastroenterology and hepatology, 2024-07

2024

Volltextzugriff (PDF)

Increased risk of fragility fractures in patients with primary biliary cholangitis

JBMR plus, 2024-07, Vol.8 (7), p.ziae056-ziae056

2024

Volltextzugriff (PDF)

Limited Generalizability of Retrospective Single-Center Cohort Study in Comparison to Multicenter Cohort Study on Prognosis of Hepatocellular Carcinoma

Journal of hepatocellular carcinoma, 2024-07, Vol.11, p.1235-1249

2024

Volltextzugriff (PDF)

간섬유화를 동반한 비알코올 지방간염 환자를 대상으로 한 Resmetirom 3상, 무작위 대조 임상시험

대한소화기학회지, 2024, 83(6), , pp.253-255

2024

Volltextzugriff (PDF)

A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis

The Korean journal of gastroenterology, 2024-06, Vol.83 (6), p.253-255

2024

Volltextzugriff (PDF)

THU-394 Improvement of hepatitis C virus care cascade by In-hospital Reflex tEsting ALarm-C (REAL-C) model

Journal of hepatology, 2024-06, Vol.80, p.S822-S822

2024

Volltextzugriff (PDF)

TOP-157 Risk of extrahepatic malignancies in patients with autoimmune hepatitis: a nationwide cohort study

Journal of hepatology, 2024-06, Vol.80, p.S305-S305

2024

Volltextzugriff (PDF)

The associations between fibrosis changes and liver‐related events in patients with metabolic dysfunction‐associated steatotic liver disease

Liver international, 2024-06, Vol.44 (6), p.1448-1455

2024

Volltextzugriff (PDF)

SAT-272 Updated definition of healthy alanine aminotransferase levels in a metabolically and histologically normal population

Journal of hepatology, 2024-06, Vol.80, p.S144-S144

2024

Volltextzugriff (PDF)

Improving the hepatitis C virus care cascade with the in‐hospital Reflex tEsting ALarm‐C (REAL‐C) model

Liver international, 2024-05, Vol.44 (5), p.1243-1252

2024

Volltextzugriff (PDF)

CAMP‐B score predicts the risk of hepatocellular carcinoma in patients with chronic hepatitis B after HBsAg seroclearance

Alimentary pharmacology & therapeutics, 2024-05, Vol.59 (10), p.1223-1235

2024

Volltextzugriff (PDF)

Response to atezolizumab plus bevacizumab specific for lung and lymph node metastases affects survival of patients with HCC

Liver international, 2024-04, Vol.44 (4), p.907-919

2024

Volltextzugriff (PDF)

Linvencovir: Paving the way for functional cure in hepatitis B

Clinical and molecular hepatology, 2024-04, Vol.30 (2), p.164

2024

Volltextzugriff (PDF)

Letter: Cardiovascular risk of tenofovir disoproxil fumarate or tenofovir alafenamide fumarate in patients with chronic hepatitis B: More questions than an answer - author’s reply

Clinical and molecular hepatology, 2024-04, Vol.30 (2), p.272

2024

Volltextzugriff (PDF)

Abstract 984: Optimizing first-line systemic therapy selection in advanced hepatocellular carcinoma (HCC): A biomarker approach using circulating cell-free DNA (cfDNA) (atezolizumab plus bevacizumab vs. lenvatinib vs. sorafenib)

Cancer research (Chicago, Ill.), 2024-03, Vol.84 (6_Supplement), p.984-984

2024

Volltextzugriff (PDF)

1 – 25 von 191

Suche als RSS-Feed

Aktive Filter

ThemaHepatitis B, Chronic - Drug Therapy

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(185)
Mit Volltextzugriff
(177)

Publikationsform

Sprache

Englisch
(167)
Koreanisch
(24)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Updated Reference Intervals for Alanine Aminotransferase in a Metabolically and Histologically Normal Population

Stereotactic body radiotherapy alone versus stereotactic body radiotherapy after incomplete transarterial therapy for hepatocellular carcinoma

Higher risk of proteinuria with atezolizumab plus bevacizumab than lenvatinib in first-line systemic treatment for hepatocellular carcinoma

Revisiting the steatosis‐associated fibrosis estimator score in young Asian subjects with steatotic liver disease and consideration for population variability

Clinical and Radiologic Predictors of Response to Atezolizumab-Bevacizumab in Advanced Hepatocellular Carcinoma

Viral Load-Based Prediction of Hepatocellular Carcinoma Risk in Noncirrhotic Patients With Chronic Hepatitis B : A Multinational Study for the Development and External Validation of a New Prognostic Model

Outcomes of liver resection and transarterial chemoembolization in patients with multinodular BCLC-A hepatocellular carcinoma

Dynamic liver volume change in predicting hepatic decompensation and long‐term effects of stereotactic body radiation therapy

A Study on the Improvement of the Superconducting Magnet System for the 28 GHz SC-ECRIS at KBSI

Tenofovir Is Associated With a Better Prognosis Than Entecavir for Hepatitis B Virus–Related Hepatocellular Carcinoma

Increased risk of fragility fractures in patients with primary biliary cholangitis

Limited Generalizability of Retrospective Single-Center Cohort Study in Comparison to Multicenter Cohort Study on Prognosis of Hepatocellular Carcinoma

간섬유화를 동반한 비알코올 지방간염 환자를 대상으로 한 Resmetirom 3상, 무작위 대조 임상시험

A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis

THU-394 Improvement of hepatitis C virus care cascade by In-hospital Reflex tEsting ALarm-C (REAL-C) model

TOP-157 Risk of extrahepatic malignancies in patients with autoimmune hepatitis: a nationwide cohort study

The associations between fibrosis changes and liver‐related events in patients with metabolic dysfunction‐associated steatotic liver disease

OS-121 Multinational randomized trial to investigate the efficacy of tenofovir alafenamide in reducing adverse clinical events in chronic hepatitis B patients who are beyond treatment indications by current guidelines (ATTENTION trial): first interim analysis

SAT-272 Updated definition of healthy alanine aminotransferase levels in a metabolically and histologically normal population

Improving the hepatitis C virus care cascade with the in‐hospital Reflex tEsting ALarm‐C (REAL‐C) model

CAMP‐B score predicts the risk of hepatocellular carcinoma in patients with chronic hepatitis B after HBsAg seroclearance

Response to atezolizumab plus bevacizumab specific for lung and lymph node metastases affects survival of patients with HCC

Linvencovir: Paving the way for functional cure in hepatitis B

Letter: Cardiovascular risk of tenofovir disoproxil fumarate or tenofovir alafenamide fumarate in patients with chronic hepatitis B: More questions than an answer - author’s reply

Abstract 984: Optimizing first-line systemic therapy selection in advanced hepatocellular carcinoma (HCC): A biomarker approach using circulating cell-free DNA (cfDNA) (atezolizumab plus bevacizumab vs. lenvatinib vs. sorafenib)

Aktive Filter

Suchergebnisse filtern